Literature DB >> 20237930

Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome.

Bum-Su Choung1, Wan-Hee Yoo.   

Abstract

Sjogren's syndrome (SS) is a systemic autoimmune disease characterized by xerophthalmia, xerostomia and extraglandular manifestations. Anemia, leukopenia, thrombocytopenia and lymphoproliferative disorders, including lymphoma are well-known extraglandular, hematological complications of SS. We report here a rare case of patient with primary SS who developed pancytopenia with severe thrombocytopenia as an initial manifestation and successfully treated with IV immunoglobulin (IVIG). The present case suggests that pancytopenia with severe thrombocytopenia can be a difficult-to-treat abnormality, and initial manifestation of primary SS and IVIG might be an effective treatment for severe thrombocytopenia refractory to high-dose steroid in primary SS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237930     DOI: 10.1007/s00296-010-1395-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

Review 1.  The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases.

Authors:  D Pyne; M Ehrenstein; V Morris
Journal:  Rheumatology (Oxford)       Date:  2002-04       Impact factor: 7.580

2.  Five-year efficacy of intravenous gammaglobulin to treat dysautonomia in Sjögren's syndrome.

Authors:  J L Dupond; H Gil; B de Wazieres
Journal:  Am J Med       Date:  1999-01       Impact factor: 4.965

3.  A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study.

Authors:  K Asmussen; V Andersen; G Bendixen; M Schiødt; P Oxholm
Journal:  J Intern Med       Date:  1996-06       Impact factor: 8.989

4.  Dramatic response to intravenous high dose gamma-globulin in refractory vasculitis of the skin associated with Sjögren's syndrome.

Authors:  P Durez; L Tourné; W Feremans; F Mascart-Lemone; M Heenen; T Appelboom
Journal:  J Rheumatol       Date:  1998-05       Impact factor: 4.666

5.  Thrombocytopenia in patients with Sjögren's syndrome.

Authors:  S Sugai; J Tachibana; S Shimizu; S Konda
Journal:  Arthritis Rheum       Date:  1989-02

Review 6.  Primary Sjogren syndrome: clinical and immunopathologic features.

Authors:  R I Fox; F V Howell; R C Bone; P Michelson
Journal:  Semin Arthritis Rheum       Date:  1984-11       Impact factor: 5.532

7.  Sjögren's syndrome associated with chronic hepatitis C, severe thrombocytopenia, hypertrophic cardiomyopathy, and diabetes mellitus.

Authors:  Takeshi Kamimura; Hidetomo Sato; Masahiro Iwamoto; Hiroyuki Nara; Kimiaki Torikoe; Jun-Ichi Masuyama; Hitoaki Okazaki; Seiji Minota
Journal:  Intern Med       Date:  2005-06       Impact factor: 1.271

8.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.

Authors:  E N Harris; R A Asherson; A E Gharavi; S H Morgan; G Derue; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

9.  Cell-mediated immune-pancytopenia complicating primary Sjögren's syndrome.

Authors:  T Seki; K Kiyosawa; S Monno; Y Imai; K Furukawa; S Kumazawa; M Ota; H Saito; S Furuta; T Nakahata
Journal:  Am J Hematol       Date:  1993-07       Impact factor: 10.047

10.  Haematological manifestations of primary Sjögren's syndrome: a clinicopathological study.

Authors:  R Ramakrishna; K Chaudhuri; A Sturgess; A Manoharan
Journal:  Q J Med       Date:  1992-07
View more
  5 in total

1.  Mikulicz's Disease With Immune Thrombocytopenia: A New Immunoglobulin G4-Mediated Disorder and Literature Review.

Authors:  Shu Li; Cong Deng; Jinwei Chen; Fen Li
Journal:  Arch Rheumatol       Date:  2018-11-30       Impact factor: 1.472

2.  High-dose methylprednisolone pulse therapy upregulated FcγRIIb expression on B cells in primary Sjögren's syndrome patients with thrombocytopenia.

Authors:  Haifeng Chen; Shiliang Zhou; Dinglei Su; Liwei Lu; Xia Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2013-08-06       Impact factor: 2.980

3.  Disseminated histoplasmosis in primary Sjögren syndrome: A case report.

Authors:  Jia-Ai Li; Ying-Ying Cheng; Zhi-Tao Cui; Wei Jiang; Wu-Qiong Zhang; Zhong-Hua Du; Bin Gao; Yin-Yin Xie; Hong-Mei Meng
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

4.  Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.

Authors:  Yuan Liu; Shiju Chen; Yuechi Sun; Qingyan Lin; Xining Liao; Junhui Zhang; Jiao Luo; Hongyan Qian; Lihua Duan; Guixiu Shi
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

5.  Clinical Characteristics of Secondary Immune Thrombocytopenia Associated With Primary Sjögren's Syndrome.

Authors:  Fan Dai; Guomei Yang; Peishi Rao; Puqi Wu; Rongjuan Chen; Yuechi Sun; Yun Peng; Hongyan Qian; Bin Wang; Shiju Chen; Yuan Liu; Guixiu Shi
Journal:  Front Med (Lausanne)       Date:  2020-04-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.